InnoCan Pharma Corporation (INNPF)
Market Closed
2 Jul, 20:00
OTC PINK OTC PINK Primary $
1. 60
-0.14
-8.046%
$
7.2M Market Cap
- P/E Ratio
- Div Yield
100 Volume
0 Eps
$ 1.74
Previous Close Want to track INNPF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Innocan Pharma to Present at the 2024 ThinkEquity Conference
Herzliya, Israel and Calgary, Alberta, October 21, 2024 – PRISM MediaWire – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in chronic pain management via Liposomal CBD drug products, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental
Prismmediawire | 1 year ago
